PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients)
Recruiting
Observational Study
Pre-eclampsia
Oocyte Donation
Pre-Eclampsia; Complicating Pregnancy
Pre-Eclampsia; Mild
Pre-Eclampsia, Severe
Pre-eclampsia or Eclampsia With Pre-existing Hypertension
ART
Neonatal Morbidity
Neonatal Mortality
Placental Abruption
Gestational Diabetes
Preterm Labor
Post-partum Hemorrhage (PPH)
Intrauterine Growth Restriction (IUGR)
Hypertensive Disorders of Pregnancy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Observational
- Participants needed
- 462 (estimated)
- Sponsor
- Copenhagen University Hospital, Hvidovre · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of this prospective observational cohort study is to investigate the pathophysiological mechanisms behind and risk of pre-eclampsia in women pregnant after fertility treatment with oocyte donation. The participants are included in of of two cohorts. One includes women pregnant after oocyte donation whereas the other includes women pregnant after IVF treatment with autologous oocytes.
Part…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age \> 18 years
* BMI \< 35 kg/m2
* Normal wet smear within the past three years
* Both nulli- and multiparous
* Singletons and multiple gestations
Exclusion Criteria:
* Age \< 18 years
* BMI \> 35 kg/m2
* HIV/ hepatitis
* Essential hypertension
* Chronic kidney disease
* Un…
Contacts
No contact information available.